Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,626.00
+19.50 (1.21%)
May 11, 2026, 3:29 PM IST
Wockhardt Revenue
In the fiscal year ending March 31, 2026, Wockhardt had annual revenue of 34.84B INR with 14.79% growth. Wockhardt had revenue of 10.10B in the quarter ending March 31, 2026, with 31.85% growth.
Revenue
34.84B
Revenue Growth
+14.79%
P/S Ratio
7.49
Revenue / Employee
15.17M
Employees
2,296
Market Cap
261.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 34.84B | 4.49B | 14.79% |
| Mar 31, 2025 | 30.35B | 2.05B | 7.24% |
| Mar 31, 2024 | 28.30B | 1.73B | 6.51% |
| Mar 31, 2023 | 26.57B | -5.73B | -17.74% |
| Mar 31, 2022 | 32.30B | 5.22B | 19.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ipca Laboratories | 95.06B |
| Emcure Pharmaceuticals | 92.16B |
| Piramal Pharma | 88.69B |
| Alembic Pharmaceuticals | 72.67B |
| Gland Pharma | 61.13B |
| Ajanta Pharma | 56.25B |
| Strides Pharma Science | 47.26B |
| NATCO Pharma | 45.63B |
Wockhardt News
- 4 days ago - Top losers today: godrej consumer products at ₹1,036.60 down 5.26%, wockhardt at ₹1,637.50 falls 4.62%, brigade enterprises at ₹773.15 slips 4.43% - Business Upturn
- 4 days ago - Top losers in morning trade: godrej consumer products at ₹1,043.40 down 4.63%, KPIT technologies at ₹715.00 falls 4.49%, wockhardt at ₹1,643.50 slips 4.28% - Business Upturn
- 4 days ago - Pharma sector stocks today, May 7: Wockhardt falls 4%, Panacea Biotec jumps 2.16%, Biocon up 1% - Business Upturn
- 5 days ago - Top gainers in morning trade: wockhardt at ₹1,731.30 up 12.64%, tejas networks at ₹477.80 up 12.27%, coforge at ₹1,272.50 up 8.87% - Business Upturn
- 5 days ago - Pharma sector stocks rises today, May 6: Wockhardt jumps 7.16%, Ajanta Pharma surges 3.56%, Lupin up 1.60% - Business Upturn
- 6 days ago - Top gainers in morning trade: wockhardt at ₹1,567.70 up 10.01%, quess corp at ₹229.50 up 8.44%, Tata technologies at ₹636.95 up 7.77% - Business Upturn
- 6 days ago - Pharma sector stocks today, May 5: Wockhardt surges over 8%, Strides Pharma rises 1.81%, Natco Pharma up 1.36% - Business Upturn
- 6 days ago - Why are Wockhardt share price up over 10% today? Explained - Business Upturn